Southern California Permanente Medical Group — Los Angeles, California

Public research footprint of Southern California Permanente Medical Group, compiled from the ClinicalTrials.gov public registry.

130

Registered studies

Active

Recruiting now

107

Completed

Stopped or withdrawn

Most-studied conditions

Sarcoma · Neoplasms, Connective and Soft Tissue · Epidermal Growth Factor Receptor (EGFR)-Mutated Non Small Cell Lung… · Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia

Recently updated registry entries

NCT04879329 — A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That… (Recruiting)
NCT05248646 — Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN) (Active Not Recruiting)
NCT04899336 — A Study of Vaccination With 9-valent Extraintestinal Pathogenic Escherichia Coli Vaccine… (Completed)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Southern California Permanente Medical Group?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.